Quanterix Corp Sustainability Reports
Quanterix Corporation develops ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its proprietary Simoa technology allows researchers to examine biomarkers at extremely low concentrations.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG0027NWC78
7 reports from 2017 to 2025